Voglibose has no effect on the pharmacokinetics of hydrochlorothiazide. 1998

P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl

UI MeSH Term Description Entries
D007294 Inositol An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction. Myoinositol,Chiro-Inositol,Mesoinositol,Chiro Inositol
D008297 Male Males
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006852 Hydrochlorothiazide A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. Dichlothiazide,Dihydrochlorothiazide,Esidrex,Esidrix,HCTZ,HydroDIURIL,Hypothiazide,Oretic,Sectrazide
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D065089 Glycoside Hydrolase Inhibitors Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. alpha-Glucosidase Inhibitor,alpha-Glucosidase Inhibitors,Intestinal alpha-Amylase Inhibitors,Pancreatic alpha-Amylase Inhibitors,alpha-Amylase Inhibitors, Pancreatic,Hydrolase Inhibitors, Glycoside,Inhibitor, alpha-Glucosidase,Inhibitors, Glycoside Hydrolase,Inhibitors, Intestinal alpha-Amylase,Inhibitors, Pancreatic alpha-Amylase,Inhibitors, alpha-Glucosidase,Intestinal alpha Amylase Inhibitors,Pancreatic alpha Amylase Inhibitors,alpha Amylase Inhibitors, Pancreatic,alpha Glucosidase Inhibitor,alpha Glucosidase Inhibitors,alpha-Amylase Inhibitors, Intestinal

Related Publications

P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
January 1994, European journal of clinical pharmacology,
P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
July 1999, European journal of clinical pharmacology,
P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
November 1999, Journal of clinical pharmacology,
P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
November 2014, International journal of clinical pharmacology and therapeutics,
P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
August 1996, British journal of clinical pharmacology,
P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
October 1998, British journal of anaesthesia,
P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
December 2021, Therapeutic drug monitoring,
P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
November 2014, Journal of clinical pharmacology,
P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
July 2015, The Annals of pharmacotherapy,
P Kleist, and Y Suzuki, and T Thomsen, and M Möller, and A Römer, and H P Hucke, and M Kurowski, and K M Eckl
June 2010, Clinical pharmacokinetics,
Copied contents to your clipboard!